Position in PFE
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$2,994,444
-$353,085 QoQ
Shares Held
124,354
+4.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.47%
of 13F equity value
Holder Rank
#796
of 2,821 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Old North State Wealth Management, LLC holds $15,824,159 across 7 Drug Manufacturers - General names. PFE ranks #3 (18.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BIIB |
Biogen Inc.
|
24,720 | $5,341,003 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
24,892 | $3,144,855 | |
| 3 | PFE |
Pfizer Inc
This page
|
124,354 | $2,994,444 | |
| 4 | MRK |
Merck & Co., Inc.
|
17,648 | $2,267,768 | |
| 5 | JNJ |
Johnson & Johnson
|
4,447 | $1,129,404 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
12,246 | $705,614 | |
| 7 | ABBV |
AbbVie Inc.
|
958 | $241,071 |
All Filings in PFE
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,994,444 | 124,354 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $3,347,529 | 119,214 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $2,758,944 | 110,801 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $2,588,232 | 101,579 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $2,441,452 | 100,720 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $2,236,331 | 88,253 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $2,107,569 | 79,441 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $1,859,308 | 64,247 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $1,567,215 | 56,012 | Shares | Sole | 2024-10-29 | |
| 2024-03-31 | $1,420,800 | 51,200 | Shares | Sole | 2024-10-29 | |
| No filing history on record for this holder in this stock. | ||||||